| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2031255-23-7 | Ibrutinib dimer |
≥98% | | 询价 |
| 2 | 105925-39-1 | Tubulin inhibitor 6 |
≥98% | | 询价 |
| 3 | 143797-63-1 | SB-200646 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 54142-77-7 | 2-Keto-D-galactose |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 26853-31-6 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 20844-48-8 | Azido-PEG2-t-butyl ester |
≥98% | | 询价 |
| 7 | 134377-69-8 | Safironil |
≥98% | | 询价 |
| 8 | 3511-16-8 | Hetacillin |
≥98% | | 询价 |
| 9 | 491833-29-5 | Eliglustat(GENZ-112638,Genz 99067,Cerdelga) |
≥98% | | 询价 |
| 10 | 6859-20-7 | Ruvoside |
≥98% | | 询价 |
| 11 | 1835759-78-8 | Aminooxy-PEG4-propargyl |
≥98% | | 询价 |
| 12 | 34031-32-8 | Auranofin |
≥98% | | 询价 |
| 13 | | Bis-PEG11-NHS ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 254435-95-5 | Alisporivir |
≥98% | | 询价 |
| 15 | 1084893-56-0 | (S)-CR8 |
≥98% | | 询价 |
| 16 | 228851-54-5 | S-23906-1 |
≥98% | | 询价 |
| 17 | 78281-73-9 | AHR-10037 |
≥98% | | 询价 |
| 18 | 4350-09-8 | Oxitriptan |
≥98% | | 询价 |
| 19 | 478-84-2 | Bromolysergide |
≥98% | | 询价 |
| 20 | 78654-44-1 | Amicoumacin A |
≥98% | | 询价 |
| 21 | 110545-79-4 | Sch 40120 |
≥98% | | 询价 |
| 22 | 163706-06-7 | Cangrelor free acid |
≥98% | | 询价 |
| 23 | 3326-31-6 | 6-FITC |
≥98% | | 询价 |
| 24 | 82-02-0 | Khellin |
≥98% | | 询价 |
| 25 | 7433-10-5 | Butidrine |
≥98% | | 询价 |
| 26 | 138107-58-1 | Ro 43-5054 |
≥98% | | 询价 |
| 27 | 69245-38-1 | Rudolfomycin |
≥98% | | 询价 |
| 28 | 70958-86-0 | YM 09538 |
≥98% | | 询价 |
| 29 | 2615-15-8 | Hexaethylene glycol |
≥98% | | 询价 |
| 30 | 1383551-17-4 | SRT3657 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 1798-09-0 | 3-Methoxyphenylacetic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 5405-41-4 | Ethyl 3-hydroxybutyrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 1473404-51-1 | Hck-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 500-99-2 | 3,5-Dimethoxyphenol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 19013-07-1 | Demethoxyencecalin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 3685-26-5 | trans-4-Hydroxycyclohexanecarboxylic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 4839-46-7 | 3,3-Dimethylglutaric acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 1313730-14-1 | CCR2 antagonist 4 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 22031-64-7 | (E)-Cinnamamide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 874-14-6 | 1,3-Dimethyluracil |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 127308-98-9 | Zamifenacin fumarate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 98-89-5 | Cyclohexanecarboxylic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 1002-57-9 | 8-Aminooctanoic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 1360540-82-4 | Wnt pathway activator 2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 1401436-95-0 | Zandelisib |
≥98% | | 询价 |
| 46 | 7414-56-4 | AMP-PCP disodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 80-68-2 | DL-Threonine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 7488-99-5 | α-Carotene |
≥98% | | 询价 |
| 49 | 2033-89-8 | 3,4-Dimethoxyphenol |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 141-01-5 | Iron(II)fumarate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 5144-89-8 | o-Phenanthroline monohydrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | | Synucleozid HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 42494-73-5 | bpV(phen) |
≥98% | | 询价 |
| 54 | 100403-19-8 | Ceramides Mixture |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 1422365-94-3 | IM156 acetate(HL156A HL271 acetate) |
≥98% | | 询价 |
| 56 | 99-94-5 | p-Toluic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 28315-93-7 | 5-Hydroxy-1-tetralone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 118-90-1 | o-Toluic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 1131-94-8 | Isohomovanillic acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 516-90-5 | Taurolithocholic acid |
≥98% | | 询价 |
m.cnreagent.com